← Eichor
Condition: Visceral Adipose Tissue Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Visceral Adipose Tissue

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With Obesity
NA · 1 location(s) · Nantes University Hospital · NCT07027033
Effects of Barley Green on Visceral Fat Area in the Human Body and Investigation Into the Associated Mechanism of Intest
NA · 1 location(s) · Peking University People's Hospital · NCT06886048
IUS Combined With VAT Predicts Anti-TNF-α Efficacy in Patients With IBD: a Prospective Study
Phase N/A · 1 location(s) · The Third Xiangya Hospital of Central South University · NCT06165029
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
Phase N/A · 1 location(s) · University of Alberta · NCT07187830
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Phase N/A · 1 location(s) · Osaka Metropolitan University · NCT06694012
IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT07361874
Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian Populations
Phase N/A · 1 location(s) · National Medical Research Center for Therapy and Preventive · NCT07604610
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.